Pharmacologic treatments for covid-19 patients

Peginterferon Lambda-1 vs Placebo

This comparison will not be updated. Last search date 14 Dec, 2022


Outpatients

Forest plots
(last update: 2022-10-07)

Summary of findings
(last update: 2022-10-14)

Hospitalized patients

Forest plots
(last update: 2022-08-18)

To access all information :

You can print it as a pdf. You can also click on each forest plot with your right mouse button and download.

Permanent URL for this comparison: https://covid-nma.com/living_data/index.php?comparison=160

Back to your research

Trial Funding Comparisons Design Participants Sample size Overall risk
of bias
Highest assessment
Full description
Treatment 1 Treatment 2
NCT04343976
Chung R, Unpublished, 2022
Full text
Not reported/unclear

Peginterferon Lambda-1

Placebo

RCT Patients with confirmed COVID-19 (mild to severe) admitted to a single center in USA N=14
Some concerns
Details

Full description

NCT04354259
ILIAD
Feld JJ, Lancet Respir Med, 2021
Full text
Commentary
Commentary
Mixed

Peginterferon Lambda-1

Placebo

RCT Outpatients with confirmed COVID-19 (mild) tested at 6 centers in Canada N=60
Some concerns
Details

Full description

NCT04331899
Jagannathan P, Nature, 2021
Full text
Commentary
Commentary
Mixed

Peginterferon Lambda-1a

Placebo

RCT Outpatients with confirmed COVID-19 (asymptomatic/symptomatic, mild) treated at a single center in the USA N=120
Some concerns
Details

Full description